Novavax vaccine 89% effective against COVID-19 in the UK study, but less against the South African variant; the shares rise
Novavax stock grows by more than 20% after COVID-19 vaccine study showed almost 90% effectiveness in the UK, but less than the new South African variant
The commercial front of AMC shares may prevent bankruptcy, but the cinema operator still faces years of recovery
Apple surpasses Amazon to become the most valuable brand in the world, while Tesla is the fastest growing
